Another link between amino acid metabolism and GBM immune invasion has been demonstrated in studies exploring the role of indoleamine 2,3-dioxygenase 1 (IDO1) (Zhai et al., 2015; Valtorta et al., 2020). This evidence concerns the gene IDO1 and glioblastoma.